Skip to main content
Quest Diagnostics

Copeptin Stimulation by Combined Intravenous Arginine and Oral LevoDopa/Carbidopa in Healthy Short Children and Children with the Polyuria-Polydipsia Syndrome

Copeptin Stimulation by Combined Intravenous Arginine and Oral LevoDopa/Carbidopa in Healthy Short Children and Children with the Polyuria-Polydipsia Syndrome

Authors: March CA, Sastry S, McPhaul MJ, Wheeler SE, Garibaldi L

Citation: Horm Res Paediatr. 2024 May 3:1-11. doi: 10.1159/000539208. Online ahead of print.

Specialties: Cardiology, Endocrinology, Pediatrics

Realted content

Conference Presentation
Serum Copeptin Concentrations During Water Deprivation Test in Children With Primary Polydipsia
Conference Presentation
The Effects of Combined Arginine and Sinemet Stimulation on Copeptin Levels in the Pediatric Population
Conference Presentation
Extremely elevated serum copeptin concentrations following venipuncture may affect proper interpretation of copeptin measurements in children
Conference Presentation
Stimulated Copeptin Response to Arginine Insulin Tolerance Test A Novel Method to Assess Posterior Pituitary Function

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.